Private Portfolio Partners LLC Gilead Sciences, Inc. Transaction History

Private Portfolio Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $281,402 - $326,760	-3,890 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $34,258 - $43,880	547 Added 16.36%	3,890 $290,000
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $61 - $67	1 Added 0.03%	3,343 $217,000
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $4,875 - $5,382	-78 Reduced 2.28%	3,342 $212,000
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $211,595 - $237,279	3,420 New	3,420 $231,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Private Portfolio Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Private Portfolio Partners LLC with notifications on news.